How well do vaccine antibodies fight different COVID variants?

When you get vaccinated, your body makes antibodies to fight the virus. But how well do those defenders recognize and stop newer, different-looking variants? Researchers looked at blood samples from 100 people who were vaccinated and boosted to see what their antibodies could do in lab tests. They found that about 61 out of 100 samples could effectively neutralize the original Wuhan strain of the virus. However, the story changed with newer variants. Among those samples that worked against the original, only about 1 in 5 also showed the ability to cross-neutralize the Beta and Delta variants. Among that smaller group, about two-thirds could neutralize Omicron. The analysis also suggested that people who had been both vaccinated and previously infected showed stronger neutralizing responses than those who were just vaccinated and boosted. In a separate lab test looking at a potential risk called antibody-dependent enhancement (ADE), which in theory could make infection worse, it was observed in just 1 of the 100 samples. It's important to remember this is a retrospective look back at lab data from a single group of 100 people. The tests were done in dishes, not in people, so we don't know exactly how these findings translate to real-world protection against getting sick. The results highlight that our antibody defenses can be quite specific, which is why scientists continuously reassess vaccine strategies as the virus evolves.